144 related articles for article (PubMed ID: 11502944)
1. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Luef G; Abraham I; Trinka E; Unterberger I; Hoppichler F; Bauer G; Lechleitner M
Neurology; 2001 Aug; 57(3):565-6. PubMed ID: 11502944
[No Abstract] [Full Text] [Related]
2. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lamotrigine and valproate with respect to quality of life.
Reed RC; Giordano S
Epilepsy Behav; 2003 Feb; 4(1):88-9; reply 89-90. PubMed ID: 12609233
[No Abstract] [Full Text] [Related]
4. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
5. Valproate and lamotrigine in children and adolescents with drop attacks: follow-up after the first year.
Thomé-Souza S; Valente KD
Epilepsia; 2011 Nov; 52(11):2139. PubMed ID: 22032792
[No Abstract] [Full Text] [Related]
6. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
Biton V; Levisohn P; Hoyler S; Vuong A; Hammer AE
J Child Neurol; 2003 Feb; 18(2):133-9. PubMed ID: 12693782
[TBL] [Abstract][Full Text] [Related]
7. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
8. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
9. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Morris GL; Hammer AE; Kustra RP; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid.
Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Morales MD;
Seizure; 2010 Sep; 19(7):432-8. PubMed ID: 20663691
[TBL] [Abstract][Full Text] [Related]
12. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
13. Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy.
Stephen LJ; Sills GJ; Leach JP; Butler E; Parker P; Hitiris N; Leach VM; Wilson EA; Brodie MJ
Epilepsy Res; 2007 Jul; 75(2-3):122-9. PubMed ID: 17553671
[TBL] [Abstract][Full Text] [Related]
14. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
Thome-Souza S; Valente KD
Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
[TBL] [Abstract][Full Text] [Related]
15. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.
Nicolson A; Appleton RE; Chadwick DW; Smith DF
J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):75-9. PubMed ID: 14707312
[TBL] [Abstract][Full Text] [Related]
16. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.
Morrell MJ; Isojärvi J; Taylor AE; Dam M; Ayala R; Gomez G; O'Neill F; Tennis P; Messenheimer J
Epilepsy Res; 2003 May; 54(2-3):189-99. PubMed ID: 12837570
[TBL] [Abstract][Full Text] [Related]
17. Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study.
Kwan P; Yip FP; Hui AC; Leung H; Ng PW; Hui KF; Chan IH; Chan MH; Lam CW
Epilepsy Behav; 2009 Apr; 14(4):610-6. PubMed ID: 19435587
[TBL] [Abstract][Full Text] [Related]
18. Stable weight during lamotrigine therapy: a review of 32 studies.
Devinsky O; Vuong A; Hammer A; Barrett PS
Neurology; 2000 Feb; 54(4):973-5. PubMed ID: 10690996
[TBL] [Abstract][Full Text] [Related]
19. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W
Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134
[TBL] [Abstract][Full Text] [Related]
20. How to replace lamotrigine with valproate.
Steinhoff BJ
Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
